Rare diseases
Investigational molecules
Locations
Back to the Netherlands1 624 clinical trials in Dordrecht, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)A study to test if BHV-8000 is effective and safe for adults with early Parkinson's disease
The NetherlandsStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
The NetherlandsStudy of Amlitelimab and BI 1015550 for Patients with Interstitial Lung Disease Due to Scleroderma
The NetherlandsSafety and Efficacy of Oral Brepocitinib in Adults with Lichen Planopilaris: A Randomized, Double‑Blind, Placebo‑Controlled Phase 2/3 Study
The NetherlandsLong‑Term Safety and Tolerability of Frexalimab Drug Combination in Adults with Multiple Sclerosis
The NetherlandsImmunogenicity and safety of intradermal zoonotic influenza vaccine (H5N8) compared with intramuscular administration in adults 40–80 years with avian influenza
The NetherlandsThe NetherlandsPhase 1b study of empasiprubart in adults with multifocal motor neuropathy to assess nerve morphology by ultrasound
The NetherlandsLong‑term safety of intrathecal VO659 in participants with Huntington’s disease, spinocerebellar ataxia type 1 or type 3
The NetherlandsStudy of the safety and efficacy of intrathecal rugonersen sodium in children and adults with Angelman syndrome
The NetherlandsAcetylcysteine versus glucose placebo for reducing oxidative stress in patients after out‑of‑hospital cardiac arrest (Phase II)
The NetherlandsEfficacy and Safety of BI 1015550 in Adults with Fibrosing Interstitial Lung Disease at Risk of Disease Progression: A Randomized, Placebo‑Controlled Trial
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Acute Myeloid Leukemia (AML) and various forms of Multiple Myeloma, evaluating novel drug combinations and treatment approaches for patients ineligible for intensive chemotherapy.
Studies aim to improve survival rates and treatment outcomes in previously untreated patients.
Research centered on atherosclerotic cardiovascular disease and deep vein thrombosis, investigating new therapeutic approaches and preventive strategies.
Clinical trials focus on improving patient outcomes through innovative treatments and prevention strategies.
Studies examining treatments for thyroid conditions and hormonal disorders, comparing conventional and innovative therapeutic approaches.
Research aims to enhance treatment efficacy while minimizing side effects.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
